FCM
OYST

Farallon Capital Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Farallon Capital Management’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-230,800
Closed -$5.64M – 120
2019
Q4 		$5.64M Buy
+230,800
New +$4.05M 0.04% 109

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KXA
KPCB XIV Associates Menlo Park, California $42.8M AUM 16.52% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Farallon Capital Management's OYST Position: Q1 2020 in Review

Farallon Capital Management sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2020, closing a stake of 230,800 shares — an estimated $5.64M sold.

Farallon Capital Management first reported a position in OYST in Q4 2019 and held it in 1 quarter. The position peaked at $5.64M in Q4 2019. 43 funds tracked by Wall St. Rank hold OYST as of Q1 2020.

  • Farallon Capital Management reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Farallon Capital Management sold 230,800 Oyster Point Pharma, Inc. Common Stock shares in Q1 2020, an estimated $5.64M.
  • Farallon Capital Management first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Farallon Capital Management's Oyster Point Pharma, Inc. Common Stock position peaked at $5.64M in Q4 2019.
  • 43 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2020.

Based on Farallon Capital Management's 13F filing for Q1 2020, filed 15 May 2020.